Top Markets
Coin of the day
BioNexus Gene Lab Corporation BioNexus Gene Lab Corporation

BioNexus Gene Lab Corporation

BGLC
株式のランク #18713
BioNexus Gene Lab Corporation, a molecular diagnostics company, focuses on... BioNexus Gene Lab Corporation, a molecular diagnostics company, focuses on developing and commercializing molecular diagnostic tests for the early detection of diseases and personalized health management primarily in Malaysia. Its non-invasive blood tests are used to analyze changes in ribonucleic acid for the detection of Covid-19, Dengue, human immunodeficiency virus, human papillomavirus, and the risk potentiality of cancers diseases. BioNexus Gene Lab Corporation was incorporated in 2017 and is based in Kuala Lumpur, Malaysia with an additional office in Sheridan, Wyoming.
株価
$2.49
時価総額
$4.47M
変化(1日)
-4.01%
変化(1年)
678.16%
MY
取引 BioNexus Gene Lab Corporation (BGLC)

カテゴリー

BioNexus Gene Lab Corporation(BGLC)の発行済株式数
September 2025 時点の発行済株式数 1.80M
BioNexus Gene Lab Corporation の最新の財務報告および株価によると、現在の発行済株式数は 1.80M です。December 2023 の終わりには、同社は 1.72M 株の発行済株式 を有していました。発行済株式数は、通常、株式分割や自社株買いによって影響を受けます。
BioNexus Gene Lab Corporation(BGLC)の発行済株式数の履歴(2016 ~ 2026)
各年末時点の発行済株式数
発行済株式数 変化
2026 (TTM) 1.80M 0.83%
2024 1.78M 3.47%
2023 1.72M 19.51%
2022 1.44M 0.99%
2021 1.43M 66.36%
2020 857.65K 19.16%
2019 719.74K 30.20%
2018 552.80K -11.11%
2017 621.90K 0.00%
2016 621.90K 0.00%
類似企業や競合他社の発行済株式数
企業 発行済株式数
376.00M 20,828.46%
US
707.30M 39,268.87%
US
80.10M 4,358.21%
US
2.84B 157,753.15%
CN
283.00M 15,652.00%
US